NL-OMON43567已完成不适用
D-dimer and Factor XIII activation peptide in cerebral venous thrombosis (CVT) - D-dimer and AP-FXIII in CVT
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 520
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 18 至 99（—）
入选标准
- •Any adult patient with a clinical suspicion of CVT where the treating neurologist considers radiological investigation (CT-V or MR-V) to be required
排除标准
- 未提供
研究者
相似试验
已完成
不适用
The Role of Factor XIII Activation Peptide and D-dimer Values for the Diagnosis of Cerebral Venous Thrombosis (CVT)Cerebral Venous ThrombosisNCT00924859Insel Gruppe AG, University Hospital Bern401
尚未招募
不适用
The pharmacokinetics of plasma-derived Factor XIII in childreCongenital Factor XIII deficiencyOther -ACTRN12605000764639Department of Clinical Haematology, Royal Children's Hospital, Parkville, Victoria4
已完成
3 期
Vitamin D3: Identification of central nervous system targets using high-technology functional MRI (D-LIGHTFUL)endocriene aandoeningen, obesitas10018424ObesityNL-OMON48648Academisch Medisch Centrum60
进行中（未招募）
不适用
VITAL Study - Selective VITamin D Receptor Activator (Paricalcitol) for Albuminuria Lowering Study: A Phase 2, Prospective, Randomized, Double-blind, Placebo-controlled Multicenter Study to Evaluate the Safety and Efficacy of Paricalcitol Capsules on Reducing Albuminuria in Type 2 Diabetic Nephropathy Subjects who are Currently Being Treated with Renin-angiotensin System Inhibitors - VitalEUCTR2006-001363-31-ITAbbott GmbH & Co KG258
已完成
不适用
Clinical Trial of Factor XIII (FXIII) ConcentrateFactor XIII DeficiencyHemophiliaNCT00640289Children's Hospital of Orange County72